| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |